Advertisement
Journal Home
Search for

Volume 74, Issue 1, Pages 100-104 (1 July 2010)


View previous. 13 of 20 View next.

Sexual behavior of castrated boars treated with prostaglandin F

V. Zamoraa, J.L. FigueroaaCorresponding Author Informationemail address, M. Martíneza, M.T. Sánchez-Torresa, M. Cárdenasb, R.N. Kirkwoodc

Received 3 October 2009; received in revised form 30 January 2010; accepted 31 January 2010. published online 08 March 2010.

Abstract 

The objectives were to test the hypothesis that exogenous prostaglandin F (PGF) temporarily restores sexual behavior of castrated boars, and to evaluate effects of PGF on serum hormone concentrations. At 35 d after castration, nine lean-type adult boars were randomly assigned to three treatments in a 3×3 latin square (with three replicates). Treatments were three doses of PGF doses (0, 10, and 20mg) and three periods of treatment, with 5 d between each period. Serum testosterone (T) concentrations were non-detectable at the start of the experiment. Serum concentrations of estradiol (E2), LH, prolactin (PRL), and cortisol were unaffected (P>0.05) by PGF treatment. The interval from treatment to ejaculation in boars treated with 10mg (758s) or 20mg (660s) PGF did not differ, but were different (P < 0.05) from control boars (>1 800s). Ejaculation duration and false mounts differed (P < 0.05) between control boars and boars treated with 10 or 20mg PGF. In conclusion, PGF treatment did not change serum concentrations of T, E2, LH, PRL, or cortisol, but restored sexual behavior. This restoration may have been due to an effect of PGF directly in specific areas of the brain, or indirectly via release of other hormones that stimulated areas in the brain that affected sexual behavior.

a Programa en Ganadería, Campus Montecillo, Colegio de Postgraduados, Texcoco, Estado de México, 56 230, México

b Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, D.F. 14 000, México

c Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA

Corresponding Author InformationCorresponding author. Tel.: +52 595 952 0200; fax: +52 595 952 0279.

PII: S0093-691X(10)00072-5

doi:10.1016/j.theriogenology.2010.01.019


View previous. 13 of 20 View next.

Advertisement